Kelly L. Walton

3.3k total citations · 1 hit paper
53 papers, 2.3k citations indexed

About

Kelly L. Walton is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Rheumatology. According to data from OpenAlex, Kelly L. Walton has authored 53 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 13 papers in Public Health, Environmental and Occupational Health and 9 papers in Rheumatology. Recurrent topics in Kelly L. Walton's work include TGF-β signaling in diseases (21 papers), Reproductive Biology and Fertility (12 papers) and Muscle Physiology and Disorders (10 papers). Kelly L. Walton is often cited by papers focused on TGF-β signaling in diseases (21 papers), Reproductive Biology and Fertility (12 papers) and Muscle Physiology and Disorders (10 papers). Kelly L. Walton collaborates with scholars based in Australia, United States and United Kingdom. Kelly L. Walton's co-authors include Craig A. Harrison, Katharine E. Johnson, Yogeshwar Makanji, Paul Gregorevic, Justin L. Chen, Hongwei Qian, David Robertson, Sara L. Al-Musawi, Karen K. L. Chan and Adam Hagg and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Kelly L. Walton

53 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis

2017 445 citations Kelly L. Walton, Katharine E. Johnson et al. Frontiers in Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelly L. Walton Australia	25	1.4k	342	321	285	235	53	2.3k
Buer Sen United States	30	1.5k 1.1×	474 1.4×	172 0.5×	253 0.9×	67 0.3×	46	2.7k
Zhengjian Yan China	16	1.1k 0.8×	76 0.2×	214 0.7×	189 0.7×	119 0.5×	44	2.1k
Lijiang Ma United States	20	1.2k 0.9×	151 0.4×	98 0.3×	312 1.1×	66 0.3×	33	2.3k
Anna Di Carlo Italy	24	1.7k 1.2×	172 0.5×	260 0.8×	278 1.0×	128 0.5×	40	2.7k
Paul D. Killen United States	30	1.3k 0.9×	455 1.3×	83 0.3×	314 1.1×	248 1.1×	69	3.2k
Sabine Mazerbourg France	22	1.4k 1.0×	51 0.1×	849 2.6×	313 1.1×	227 1.0×	35	2.4k
Fumiko Itoh Japan	26	2.2k 1.6×	122 0.4×	59 0.2×	215 0.8×	143 0.6×	56	3.0k
Markku Heikinheimo Finland	21	1.3k 0.9×	84 0.2×	166 0.5×	512 1.8×	95 0.4×	81	2.1k
Ye-Guang Chen United States	14	2.9k 2.1×	129 0.4×	131 0.4×	333 1.2×	75 0.3×	16	3.6k
Guijun Yan China	31	1.4k 1.0×	169 0.5×	616 1.9×	220 0.8×	66 0.3×	107	3.4k

Countries citing papers authored by Kelly L. Walton

Since Specialization

Citations

This map shows the geographic impact of Kelly L. Walton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly L. Walton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly L. Walton more than expected).

Fields of papers citing papers by Kelly L. Walton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly L. Walton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly L. Walton. The network helps show where Kelly L. Walton may publish in the future.

Co-authorship network of co-authors of Kelly L. Walton

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly L. Walton. A scholar is included among the top collaborators of Kelly L. Walton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly L. Walton. Kelly L. Walton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harrison, Craig A., Elizabeth H. Skinner, Kimberley Haines, et al.. (2022). Activin A level is associated with physical function in critically ill patients. Australian Critical Care. 36(5). 702–707. 1 indexed citations

Houston, Brendan J., Anne E. O’Connor, Degang Wang, et al.. (2022). Human INHBB Gene Variant (c.1079T>C:p.Met360Thr) Alters Testis Germ Cell Content, but Does Not Impact Fertility in Mice. Endocrinology. 163(3). 5 indexed citations

Walton, Kelly L., Jessica M. Stringer, Amy Winship, et al.. (2022). Inhibin Inactivation in Female Mice Leads to Elevated FSH Levels, Ovarian Overstimulation, and Pregnancy Loss. Endocrinology. 163(4). 10 indexed citations

Nagykery, Nicholas, Kelly L. Walton, Craig A. Harrison, et al.. (2021). Structure of AMH bound to AMHR2 provides insight into a unique signaling pair in the TGF-β family. Proceedings of the National Academy of Sciences. 118(26). 32 indexed citations

Wilce, Matthew C. J., et al.. (2020). Engineering the Ovarian Hormones Inhibin A and Inhibin B to Enhance Synthesis and Activity. Endocrinology. 161(8). 7 indexed citations

Walton, Kelly L., Dulama Richani, Karen Chan, et al.. (2020). A variant of human growth differentiation factor-9 that improves oocyte developmental competence. Journal of Biological Chemistry. 295(23). 7981–7991. 29 indexed citations

Richani, Dulama, David Agapiou, Mark P. Hedger, et al.. (2019). Cumulin and FSH Cooperate to Regulate Inhibin B and Activin B Production by Human Granulosa-Lutein Cells In Vitro. Endocrinology. 160(4). 853–862. 12 indexed citations

Walker, Ryan G., Magdalena Czepnik, Adam Hagg, et al.. (2018). Molecular characterization of latent GDF8 reveals mechanisms of activation. Proceedings of the National Academy of Sciences. 115(5). E866–E875. 29 indexed citations

Chen, Justin L., Kelly L. Walton, Adam Hagg, et al.. (2018). Specific targeting of TGF-beta family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease. Clinical Endocrinology. 89. 19 indexed citations

10.

Patiño, Liliana Catherine, Kelly L. Walton, Thomas D. Mueller, et al.. (2017). BMP15 Mutations Associated With Primary Ovarian Insufficiency Reduce Expression, Activity, or Synergy With GDF9. The Journal of Clinical Endocrinology & Metabolism. 102(3). 1009–1019. 45 indexed citations

11.

Walton, Kelly L., Katharine E. Johnson, & Craig A. Harrison. (2017). Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis. Frontiers in Pharmacology. 8. 461–461. 445 indexed citations breakdown →

12.

Chen, Justin L., Kelly L. Walton, Hongwei Qian, et al.. (2016). Differential Effects of IL6 and Activin A in the Development of Cancer-Associated Cachexia. Cancer Research. 76(18). 5372–5382. 61 indexed citations

13.

Winbanks, Catherine E., Kate T. Murphy, Bianca C. Bernardo, et al.. (2016). Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice. Science Translational Medicine. 8(348). 348ra98–348ra98. 70 indexed citations

14.

Dynon, Kemperly, Ying Li, Tracey A. Edgell, et al.. (2014). Development of a high-throughput assay for human proprotein convertase 5/6 for detecting uterine receptivity. Analytical Biochemistry. 475. 14–21. 5 indexed citations

15.

Walton, Kelly L., Karen Chan, Enid Pruysers, et al.. (2013). Use of detergent-based buffers allows detection of precursor inhibin forms in an immunoassay format. Molecular and Cellular Endocrinology. 381(1-2). 106–114. 6 indexed citations

16.

Nicholls, Peter K., Peter G. Stanton, Justin L. Chen, et al.. (2012). Activin Signaling Regulates Sertoli Cell Differentiation and Function. Endocrinology. 153(12). 6065–6077. 50 indexed citations

17.

Makanji, Yogeshwar, Peter Temple‐Smith, Kelly L. Walton, Craig A. Harrison, & David Robertson. (2009). Inhibin B Is a More Potent Suppressor of Rat Follicle-Stimulating Hormone Release than Inhibin A in Vitro and in Vivo. Endocrinology. 150(10). 4784–4793. 32 indexed citations

18.

Walton, Kelly L., Yogeshwar Makanji, Matthew C. J. Wilce, et al.. (2009). A Common Biosynthetic Pathway Governs the Dimerization and Secretion of Inhibin and Related Transforming Growth Factor β (TGFβ) Ligands. Journal of Biological Chemistry. 284(14). 9311–9320. 62 indexed citations

19.

Walton, Kelly L., et al.. (1985). Clinical features, autoantibodies and HLA-DR antigens in rheumatoid arthritis.. PubMed. 12(2). 223–6. 18 indexed citations

20.

Walton, Kelly L.. (1951). Experiments with Dextran Sulphate as an Anticoagulant. Proceedings of the Royal Society of Medicine. 44(7). 563–564. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact